Background: Chinese data on the efficacy of low-and high-dose radioiodine for thyroid
remnant are still absent. The aim of the study was to investigate whether a low dose of …

The need for high dose radioiodine for ablation of remnants in patients with thyroid cancer is
still in question. We compared the effectiveness of high and low dose 131 I for ablation in …

Purpose: To determine the effect of the extent of thyroidectomy and additional postsurgical
radioiodine remnant ablation (RRA) on the survival of patients with differentiated thyroid …

Introduction Preparation for postoperative radioiodine ablation for differentiated thyroid
carcinoma is performed by either thyroid hormone withdrawal or recombinant human thyroid …

Background The clinical outcomes of delayed radioiodine remnant ablation (RRA) therapy
in patients with low-risk papillary thyroid carcinoma (PTC) are unclear. We aimed to evaluate …

In our hospital, a 24-h radioiodine-131 (131 I) uptake-related ablation strategy is used in
patients with differentiated thyroid cancer to destroy thyroid remnants after primary surgery …

Recently, Luster et al.[1] showed that radioiodine administration in euthyroid patients with
thyroid carcinoma is potent and safe following preparation with recombinant human TSH …

Background. The purpose of the meta-analysis was to estimate the effectiveness and toxicity
of low activity radioiodine ablation versus high activity in patients with differentiated thyroid …

Iodine kinetics were studied in patients with differentiated thyroid cancer while euthyroid
under exogenous thyroid stimulating hormone (TSH) and while hypothyroid to detect …

Radioiodine remnant ablation in low-risk differentiated thyroid cancer. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …